Capital Flow Monitor · Sponsors · CIK 1905252
Solve Therapeutics, Inc.
1025 ALAMEDA DE LAS PULGAS, SUITE 122, BELMONT, CA, 94002 · (858) 357-4137
Biotechnology · Corporation· inc. DELAWARE true 2021
Fit score
—
Offering
$120.5M
Sold
$48.2M
% sold
40.0%
Investors
16
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-11-25 | D ·current | 506(b) | $120.5M | $48.2M | 40.0% | 16 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
-
David Johnson — Executive Officer / Director, Belmont, CA
9 other raises
- VoltServer Inc. $5.0M of $8.0M · 62.5%
- Dash Bio, Inc. $30.0M of $30.0M · 100.0%
- ONclick Healthcare Inc $3.2M of $3.2M · 100.0%
- Twin City Island Spirits, Inc. $200K of $4.0M · 5.0%
- Nature's Toolbox, Inc. $10.4M of $15.0M · 69.1%
- Chestnut Oak Ridge Coal Opportunity Fund, L.P. $24.5M of $24.7M · 99.5%
- Little Kanawha Coal Opportunity Fund, L.P. $12.9M of $13.4M · 96.4%
- May Fork Coal Opportunity Fund, L.P. $18.7M of $20.3M · 91.9%
- Jack Rock Coal Opportunity Fund, L.P. $36.1M of $36.3M · 99.5%
- Peter Colabuono — Director, Belmont, CA
-
Alan Colowick — Director, Belmont, CA
1 other raise
- RECODE THERAPEUTICS, INC. $29.4M of $29.4M · 100.0%
- Langdon Miller — Executive Officer, Belmont, CA
- Jason Pitts — Director, Belmont, CA
- Clayton D. Knox — Executive Officer, Belmont, CA
- Daniel McHugh — Director, Belmont, CA
-
Robert Mittendorff — Director, Belmont, CA
3 other raises
- Numerion Labs, Inc. $19.8M of $35.0M · 56.6%
- Capital Rx, Inc. $230.8M of $232.9M · 99.1%
- Volastra Therapeutics, Inc. $30.1M of $30.1M · 100.0%
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.